Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Hartmann

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
The Journal of Allergy and Clinical Immunology|May 27, 2019
IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasisJames G Krueger, Keith A Wharton, Thomas Schlitt, et al.
Acta Biomaterialia|July 5, 2024
A 3D bioreactor model to study osteocyte differentiation and mechanobiology under perfusion and compressive mechanical loadingWyonna Darleen Rindt, Melanie Krug, Shuntaro Yamada, et al.
Epilepsy & Behavior : E&B|December 9, 2023
Alcohol for seizure induction in the epilepsy monitoring unitBrian E Emmert, Kevin Xie, Erin C Conrad, et al.
Journal of Cell Science|January 25, 2015
Decatransin, a new natural product inhibiting protein translocation at the Sec61/SecYEG transloconTina Junne, Joanne Wong, Christian Studer, et al.
Signal Transduction and Targeted Therapy|December 10, 2025
Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignanciesMichael Rassner, Tony Andreas Müller, Kirstyn Anne Crossley, et al.
Cell Host & Microbe|June 19, 2012
Selective and specific inhibition of the plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporinDominic Hoepfner, Case W McNamara, Chek Shik Lim, et al.
Blood Advances|April 10, 2024
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALLGaia Gentile, Teresa Poggio, Antonella Catalano, et al.
Vaccines|November 26, 2024
Impaired SARS-CoV-2-Specific CD8+ T Cells After Infection or Vaccination but Robust Hybrid T Cell Immunity in Patients with Multiple MyelomaKhalid Shoumariyeh, Benedikt Csernalabics, Elahe Salimi Alizei, et al.
The Journal of Experimental Medicine|January 6, 2018
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemiaErika Tissino, Dania Benedetti, Sarah E M Herman, et al.
Blood|February 2, 2020
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expressionErika Tissino, Federico Pozzo, Dania Benedetti, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
The Journal of Allergy and Clinical Immunology|May 27, 2019
IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasisJames G Krueger, Keith A Wharton, Thomas Schlitt, et al.
Acta Biomaterialia|July 5, 2024
A 3D bioreactor model to study osteocyte differentiation and mechanobiology under perfusion and compressive mechanical loadingWyonna Darleen Rindt, Melanie Krug, Shuntaro Yamada, et al.
Epilepsy & Behavior : E&B|December 9, 2023
Alcohol for seizure induction in the epilepsy monitoring unitBrian E Emmert, Kevin Xie, Erin C Conrad, et al.
Journal of Cell Science|January 25, 2015
Decatransin, a new natural product inhibiting protein translocation at the Sec61/SecYEG transloconTina Junne, Joanne Wong, Christian Studer, et al.
Signal Transduction and Targeted Therapy|December 10, 2025
Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignanciesMichael Rassner, Tony Andreas Müller, Kirstyn Anne Crossley, et al.
Cell Host & Microbe|June 19, 2012
Selective and specific inhibition of the plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporinDominic Hoepfner, Case W McNamara, Chek Shik Lim, et al.
Blood Advances|April 10, 2024
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALLGaia Gentile, Teresa Poggio, Antonella Catalano, et al.
Vaccines|November 26, 2024
Impaired SARS-CoV-2-Specific CD8+ T Cells After Infection or Vaccination but Robust Hybrid T Cell Immunity in Patients with Multiple MyelomaKhalid Shoumariyeh, Benedikt Csernalabics, Elahe Salimi Alizei, et al.
The Journal of Experimental Medicine|January 6, 2018
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemiaErika Tissino, Dania Benedetti, Sarah E M Herman, et al.
Blood|February 2, 2020
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expressionErika Tissino, Federico Pozzo, Dania Benedetti, et al.
Pageof 9